These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8456759)

  • 41. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia.
    Bradford RH; Downton M; Chremos AN; Langendörfer A; Stinnett S; Nash DT; Mantell G; Shear CL
    Ann Intern Med; 1993 Jun; 118(11):850-5. PubMed ID: 8480959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.
    Am J Cardiol; 1993 Nov; 72(14):1031-7. PubMed ID: 8213583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
    Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
    Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.
    Gengo F; Cwudzinski D; Kinkel P; Block G; Stauffer L; Lines C
    Clin Cardiol; 1995 Apr; 18(4):209-14. PubMed ID: 7788948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC; Chen CH; Tsao HM; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
    Davidson M; McKenney J; Stein E; Schrott H; Bakker-Arkema R; Fayyad R; Black D
    Am J Cardiol; 1997 Jun; 79(11):1475-81. PubMed ID: 9185636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG; McBurney CR
    Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV; Bays HE; Hassman DR; McKenney J; Chitra R; Hutchinson H; Miller E;
    Am Heart J; 2002 Dec; 144(6):1036-43. PubMed ID: 12486428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
    Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
    Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.